The Fresenius 2008T represents the next genesis of the Fresenius 2008K model hemodialysis machine. Hemodialysis is prescribed by physicians for patients with acute or chronic renal failure, when conservative therapy is judged inadequate. Dialysis therapy may be intermittent or continuous. The 2008T has the same indications for use and same intended use as the predicate device the 2008K (K994267). The Fresenius modified 2008T hemodialysis machine incorporates changes with regards to the user interface only and all water requirements, module options. functional options, performance limits, control parameters, compatible bloodlines, and language options remain unchanged from the predicate device, the 2008K (K994267).

AI/ML Overview

This 510(k) submission for the Fresenius 2008T Hemodialysis Machine primarily focuses on demonstrating substantial equivalence to a predicate device (Fresenius 2008K) due to user interface modifications only. As such, it does not involve a clinical study to establish acceptance criteria based on diagnostic performance metrics (like sensitivity, specificity, AUC). Instead, the "acceptance criteria" are related to safety and effectiveness through the lens of equivalence to the predicate device, especially regarding the modified user interface.

Therefore, many of the typical elements requested for a device that relies on clinical performance studies (e.g., sample size for test set, number of experts for ground truth, MRMC study, standalone performance) are not present in this document because they are not relevant to this specific type of submission.

Here's a breakdown of the information that is applicable or can be inferred:

1. Table of Acceptance Criteria and Reported Device Performance

Acceptance Criteria (Implicit)	Reported Device Performance (Summary from Submission)
Safety and Effectiveness Equivalence: The modified device should raise no new types of safety or effectiveness questions compared to the predicate device.	"The performance and technological characteristics of the Fresenius 2008T are equivalent to those of the Fresenius 2008K Dialysate Delivery System and raise no new types of safety or effectiveness questions." This is supported by: The 2008T having the same indications for use and same intended use as the 2008K.The modifications being limited to the user interface only.All other critical parameters (water requirements, module options, functional options, performance limits, control parameters, compatible bloodlines, and language options) remaining unchanged.Completion of a Risk Analysis where potential hazards associated with modifications were identified, mitigated, and verified as acceptable.
Intended Use Equivalence: The device must have the same intended use as the predicate.	"The intended use for the Fresenius 2008T is equivalent to that for the Fresenius 2008K Dialysate Delivery System and is as follows: Fresenius 2008T is indicated for acute and chronic dialysis therapy." (This is identical to the 2008K's intended use.)
Technological Equivalence: The technological characteristics should not introduce new safety or effectiveness concerns.	"The Fresenius 2008T is a modified version of the Fresenius 2008K Dialysate Delivery System. The performance and technological characteristics of the Fresenius 2008T are equivalent... and raise no new types of safety or effectiveness questions." This is primarily asserted by the limited scope of change (user interface) and unchanged core functionalities and performance limits.

2. Sample Size Used for the Test Set and the Data Provenance

This is not applicable as this submission is for a device modification primarily concerning the user interface of an already cleared device, not a novel device requiring a clinical performance study with a test set of patient data/samples. The assessment relies on engineering principles, risk analysis, and comparison to existing validated performance.

3. Number of Experts Used to Establish the Ground Truth for the Test Set and the Qualifications of Those Experts

Not applicable. There is no "ground truth" established in the context of diagnostic accuracy for this submission, as it's not a diagnostic device and the changes are limited to the user interface.

4. Adjudication Method for the Test Set

Not applicable.

5. If a Multi-Reader Multi-Case (MRMC) Comparative Effectiveness Study was done, If so, what was the effect size of how much human readers improve with AI vs without AI assistance

Not applicable. This device is a hemodialysis machine, not an AI-assisted diagnostic tool, and no MRMC study was performed or required for this 510(k) submission.

6. If a Standalone (i.e., algorithm only without human-in-the-loop performance) was done

Not applicable. This refers to AI/algorithm performance, which is not relevant to this device.

7. The type of ground truth used (expert consensus, pathology, outcomes data, etc.)

Not applicable in the traditional sense of a clinical diagnostic study. The "ground truth" in this context is the established safety and effectiveness of the predicate device (2008K), against which the modified 2008T is compared. The assessment hinges on demonstrating that the user interface changes do not negatively impact the device's function or safety, which is inherently tied to the predicate's proven track record. This is assessed through:

Engineering analysis
Risk assessment
Verification activities (implied by "mitigations have been verified")

8. The Sample Size for the Training Set

Not applicable. This term is used for AI/machine learning models. This submission does not involve such models.

9. How the Ground Truth for the Training Set was Established

Not applicable.

Summary of the Study that Proves the Device Meets the (Implicit) Acceptance Criteria:

The study proving the device meets the acceptance criteria is not a clinical trial involving patient data or diagnostic performance metrics. Instead, it is a comprehensive engineering assessment and risk analysis comparing the modified Fresenius 2008T to its predicate device, the Fresenius 2008K.

The key points of this "study" or justification are:

Nature of Modification: The only changes in the 2008T from the 2008K are in the user interface.
Unchanged Features: All critical operational and functional aspects remain identical to the predicate: water requirements, module options, functional options, performance limits, control parameters, compatible bloodlines, and language options.
Risk Analysis: A "Risk Analysis has been completed and potential hazards associated with the modifications have been identified, mitigated and where applicable mitigations have been verified. All potential risks were deemed acceptable after mitigation." This is the primary method for demonstrating safety and effectiveness for a change of this nature.
Indications for Use: The 2008T retains the exact same Indications for Use as the 2008K, "indicated for acute and chronic dialysis therapy."
Conclusion of Equivalence: Fresenius Medical Care North America "believes that the information provided in this submission clearly describes the Fresenius 2008T and demonstrates that it is substantially equivalent to the Fresenius 2008K Dialysate Delivery system."

In essence, the "study" is the entire 510(k) submission itself, which articulates the limited nature of the changes and provides documentation (e.g., risk analysis results, engineering specifications – though not fully detailed in this summary) to support the claim that these user interface modifications do not introduce new safety or effectiveness concerns, thus maintaining equivalence to the predicate device.

Summary

{0}------------------------------------------------

KC80964

Page 1 of 4

Image /page/0/Picture/1 description: The image shows the logo for Fresenius Medical Care. The logo consists of a symbol resembling an inverted triangle with horizontal lines inside it. Below the symbol, the text "Fresenius Medical Care" is written in a clear, bold font.

JAN 1 4 2009

510(k) Summary

A. Submitter's Information:

Name: Fresenius Medical Care North America Address: 920 Winter Street Waltham, MA 02451 Phone: (781)-699-9505

Phone:	(781) 699-9635
Fax:	(781) 699-9635
Contact Person:	Randolph Quinn, Sr. Regulatory Affairs Specialist
Date of Preparation:	3/18/2008

B. Device Name:

Trade Name:	Fresenius 2008T Hemodialysis Machine
Common/Usual Name:	Hemodialysis Machine
Classification Name:	High Permeability Hemodialysis system

60 of 289

{1}------------------------------------------------

KC80964

Page 2 of 4

Image /page/1/Picture/1 description: The image shows the logo for Fresenius Medical Care. The logo consists of an inverted triangle with horizontal lines inside, above the text "Fresenius Medical Care". The text is in a simple, sans-serif font and is left-aligned.

510(k) Summary

C. Predicate Device Name:

The Fresenius 2008T is a modified version of the Fresenius 2008K Dialysate Delivery System, which was cleared under the following premarket notification:

Fresenius 2008K #K994267 (3/16/2000) o

D. Device Description/Indications for Use:

The 2008T has the same indications for use and same intended use as the predicate device the 2008K (K994267) and is as follows:

The Fresenius 2008T is indicated for acute and chronic dialysis therapy.

E. Substantial Equivalence:

1. Is the product a device?

YES - The Fresenius 2008T is a device pursuant to 21 CFR §201 [321] (h).

1. Does the new device have the same intended use?
- YES The intended use for the Fresenius 2008T is equivalent to that for the Fresenius 2008K Dialysate Delivery System and is as follows:

Fresenius 2008T - Intended Use

Fresenius 2008T is indicated for acute and chronic dialysis therapy.

Fresenius 2008K - Intended Use

{2}------------------------------------------------

KC8C964
Page 3 of 4

Image /page/2/Picture/1 description: The image shows the logo for Fresenius Medical Care. The logo consists of a geometric shape resembling a stylized funnel or inverted pyramid, positioned above the text "Fresenius Medical Care". The geometric shape is made up of three horizontal lines that decrease in length from top to bottom, creating the funnel shape.

510(k) Summary

Fresenius 2008K is indicated for acute and chronic dialysis therapy.

3. Does the device have technological characteristics that raise new types of safety or effectiveness questions?

NO - The Fresenius 2008T is a modified version of the Fresenius 2008K Dialysate Delivery System. The performance and technological characteristics of the Fresenius 2008T are equivalent to those of the Fresenius 2008K Dialysate Delivery System and raise no new types of safety or effectiveness questions.

4. Does descriptive or performance information demonstrate equivalence?

YES - Fresenius Medical Care North America believes that the information provided in this submission clearly describes the Fresenius 2008T and demonstrates that it is substantially equivalent to the Fresenius 2008K Dialysate Delivery system.

F. Safetv Summary

The Fresenius modified 2008T hemodialysis machine incorporates changes with regards to the user interface only and all water requirements, module options. functional options, performance limits, control parameters, compatible bloodlines, and language options remain unchanged from the predicate device, the 2008K (K994267). A Risk Analysis has been completed and potential hazards associated with the modifications have been identified, mitigated and where applicable mitigations have been verified. All potential risks were deemed acceptable after mitigation.

G. General Safety and Effectiveness Concerns

Operators of the 2008T Hemodialysis machine must be trained to administer hemodialysis at the direction of a physician. In addition, the operator should be:

Knowledgeable of hemodialysis methodology and relevant physiology.
62 of 289

{3}------------------------------------------------

K080964

Page 4 of 4

Image /page/3/Picture/1 description: The image shows the logo for Fresenius Medical Care. The logo consists of a geometric shape resembling an inverted pyramid with horizontal lines inside, positioned above the text "Fresenius Medical Care". The text is in a bold, sans-serif font.

510(k) Summary

Proficient in healthcare procedures regarding aseptic techniques. 0
Thoroughly familiar with the contents of the Operator's manual. o
Fully trained and qualified to operate this machine, and able to . distinguish between normal and abnormal operation.

63 of 289

{4}------------------------------------------------

Image /page/4/Picture/0 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo is a circular seal with the words "DEPARTMENT OF HEALTH & HUMAN SERVICES (USA)" around the perimeter. Inside the circle is an abstract image of an eagle.

DEPARTMENT OF HEALTH & HUMAN SERVICES

Public Health Service

Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850

JAN 1 4 2009

Ms. Janet C. Kay Manager, Regulatory Affairs Renal Therapies Group Fresenius Medical Care North America 920 Winter Street WALTHAM MA 02451

Re: K080964

Trade/Device Name: Fresenius 2008T Hemodialysis Delivery System Regulation Number: 21 CFR §876.5860 Regulation Name: High permeability hemodialysis system Product Code: KDI Dated: December 16, 2008 Received: December 18, 2008

Dear Ms. Kay:

We have reviewed your Section 510/k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food. Drue, and Cosmetic act (Act) that do not require approval of a premarket approval application (PMA), You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration. Insting of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.

If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.

{5}------------------------------------------------

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801; good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act): 21 CFR 1000-1050.

This letter will allow you to begin marketing your device as described in your Section 510(k) premarket notification. The FDA finding os substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.

If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Office of Compliance at one of the following numbers, based on the regulation number at the top of this letter.

21 CFR 876.xxx	(Gastroenterology/Renal/Urology)	(240) 276-0115
21 CFR 884.xxx	(Obstetrics/Gynecology)	(240) 276-0115
21 CFR 892.xxx	(Radiology)	(240) 276-0120
Other		(240) 276-0100

Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding postmarket surveillance, please contact CDRH's Office of Surveillance and Biometrics' (OSB's) Division of Postmarket Surveillance at 240-276-3474. For questions regarding the reporting of device adverse events (Medical Device Reporting (MDR)), please contact the Division of Surveillance Systems at 240-276-3464. You may obtain other general information on your responsibilities under the Act from the Division of Small Manufactures. International and Consumer Assistance at its toll-free number (800) 638-2041 . or (240) 276-3150 or at its Internet address http://www.fda.gov/cdrh/industry.suppor/index.html.

Sincerely yours,
Janine M. Morris

Acting Director, Division of Reproductive, Abdominal, and Radiological Devices Office of Device Evaluation Center for Devices and Radiological Health

Enclosure

{6}------------------------------------------------

Image /page/6/Picture/0 description: The image shows the logo for Fresenius Medical Care. The logo consists of a stylized funnel shape above the text "Fresenius Medical Care". The funnel is made up of several horizontal lines that decrease in width from top to bottom.

Indications for Use

K080964 510(k) Number (if known): _

Device Name:

Fresenius 2008T Hemodialysis Machine

Indications for Use:

Fresenius 2008T is indicated for acute and chronic dialysis therapy.

Prescription Use _ X (Part 21 CFR 801 Subpart D)

AND/OR

Over-The-Counter Use (21 CFR 801 Subpart C)

(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE OF NEEDED)

Concurrence of CDRH, Office of Device Evaluation (ODE)

Page _ _ ot

(Posted November 13, 2003)

Fresenius Medical Care North America
Corporate Headquarters: 920 Winter Street Waltham, MA 02451 (781) 699-9000

(Division Sign-Off)
Division of Reproductive, Abdominal, and Radiological Devices

510(k) Number	K080964
---------------	---------

65 of 289

Regulation Number and Section

§ 876.5860 High permeability hemodialysis system.

(a)
Identification. A high permeability hemodialysis system is a device intended for use as an artificial kidney system for the treatment of patients with renal failure, fluid overload, or toxemic conditions by performing such therapies as hemodialysis, hemofiltration, hemoconcentration, and hemodiafiltration. Using a hemodialyzer with a semipermeable membrane that is more permeable to water than the semipermeable membrane of the conventional hemodialysis system (§ 876.5820), the high permeability hemodialysis system removes toxins or excess fluid from the patient's blood using the principles of convection (via a high ultrafiltration rate) and/or diffusion (via a concentration gradient in dialysate). During treatment, blood is circulated from the patient through the hemodialyzer's blood compartment, while the dialysate solution flows countercurrent through the dialysate compartment. In this process, toxins and/or fluid are transferred across the membrane from the blood to the dialysate compartment. The hemodialysis delivery machine controls and monitors the parameters related to this processing, including the rate at which blood and dialysate are pumped through the system, and the rate at which fluid is removed from the patient. The high permeability hemodialysis system consists of the following devices:(1) The hemodialyzer consists of a semipermeable membrane with an in vitro ultrafiltration coefficient (K
uf ) greater than 8 milliliters per hour per conventional millimeter of mercury, as measured with bovine or expired human blood, and is used with either an automated ultrafiltration controller or anther method of ultrafiltration control to prevent fluid imbalance.(2) The hemodialysis delivery machine is similar to the extracorporeal blood system and dialysate delivery system of the hemodialysis system and accessories (§ 876.5820), with the addition of an ultrafiltration controller and mechanisms that monitor and/or control such parameters as fluid balance, dialysate composition, and patient treatment parameters (e.g., blood pressure, hematocrit, urea, etc.).
(3) The high permeability hemodialysis system accessories include, but are not limited to, tubing lines and various treatment related monitors (e.g., dialysate pH, blood pressure, hematocrit, and blood recirculation monitors).
(b)
Classification. Class II. The special controls for this device are FDA's:(1) “Use of International Standard ISO 10993 ‘Biological Evaluation of Medical Device—Part I: Evaluation and Testing,’ ”
(2) “Guidance for the Content of 510(k)s for Conventional and High Permeability Hemodialyzers,”
(3) “Guidance for Industry and CDRH Reviewers on the Content of Premarket Notifications for Hemodialysis Delivery Systems,”
(4) “Guidance for the Content of Premarket Notifications for Water Purification Components and Systems for Hemodialysis,” and
(5) “Guidance for Hemodialyzer Reuse Labeling.”